Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis | January 8, 2020 |

Buzz on the Bullboards: Investing during midterms, inflation, & economic instability

Stocks around the world shave been rocky this week as traders awaited the full results coming from the U.S. midterm elections and crucial consumer data prices that could influence the Federal...
Jonathon Brown | November 10, 2022 |

Morning Market Outlook for Oct. 3, 2024

Stephen Whiteside of TheUpTrend.com is watching Canadian Natural Resources, China’s influence, Mideast conflict’s impact on oil stocks, action among major market ETFs and more in Thursday’s Morning Market Outlook. Navi...
TheUpTrend | October 3, 2024 |

Ultragenyx Shares Increase 30% on Results from Phase 1/2 OTC Deficiency Study

Rare disease biopharmaceutical company Ultragenyx Pharmaceutical's shares traded 30% higher after the firm reported positive topline results from Cohorts 2 and 3 in its Phase 1/2 study of DTX301 gene therapy in Ornithine Transcarbamylase Deficiency. After U.S. markets...
Streetwise Reports | January 13, 2020 |

Treasure Hunting in Fondaway Canyon Nevada

Getchell Gold Corp. ( CSE: GTCH , OTCQB: GGLDF ) a leading Nevada focused Gold and Copper exploration company was interviewed in the inaugural edition of the Canadian Securities Exchange's "Mining Mondays" program. Host, Barrington Miller interviewed Mike Sieb who is a ...
Featured Submission | July 6, 2020 |

Rich TV Live's Stocks to Watch this week (Nov. 24, 2023)

Richard De Sousa of the Rich TV Live podcast serves up his latest Stocks to Watch, exclusively for Stockhouse . Microsoft’s all-time high and its influence on the OpenAI controversy caught De Sousa’s interest this week, along with Nv...
Rich TV Live | November 24, 2023 |

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. In a press release issued September 24, PhaseBio Pharmaceuticals Inc. (PHAS...
Streetwise Reports | September 26, 2019 |

'Stay Tuned for Data' from Regenerative Medicine Firm with 'Blockbuster Opportunity'

The compelling aspects of this life sciences story are presented in a Dawson James report. In a Jan. 28 research note, analyst Jason Kolbert reported that Dawson James Securities increased its target price on Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX) to $15 pe...
Streetwise Reports | February 3, 2020 |

Basel III, Student Loans, and Bailouts: What Do They Mean for the Markets?

Andy Schectman the President of Miles Franklin Precious Metals Investments sits down with Maurice Jackson of Proven and Probable to discuss Basel III, U.S. Markets, and Bailouts and how you may benefit financially. In this comprehensive interview Mr. Schectman outli...
Maurice Jackson | December 31, 2019 |

Discover Online Value Through Advanced Intelligence Functionality

There are more than three billion social media users around the world. A company can only truly reach its full potential if it understands the depth of its online presence to connect with this audience; one Canadian artificial intelligence and machine learning Company ...
Stockhouse Editorial | February 5, 2020 |
1 2 3 4 5 6 7 8 9 10 ...